MedPath

EMTRICITABINA/TENOFOVIR DISOPROXILO ACCORD 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

EMTRICITABINA/TENOFOVIR DISOPROXILO ACCORD 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

82261

Prescription Type

Uso Hospitalario

Authorization Date

Jul 16, 2017

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number82261
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

EMTRICITABINAActive
Quantity: 200,000 mg
Name: EMTRICITABINA
TENOFOVIR DISOPROXILOActive
Quantity: 245,000 mg
Name: TENOFOVIR DISOPROXILO

ATC CLASSIFICATION (3)

J05A
J05AR
J05AR03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.